Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02979899
Title A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA (TAPPAS)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications

angiosarcoma

Therapies

Pazopanib

Carotuximab + Pazopanib

Age Groups: adult | child | senior
Covered Countries USA | ITA | FRA | ESP | DEU | AUT


No variant requirements are available.